Impact of tenofovir vs. entecavir treatment on progression of chronic hepatitis B: A nationwide cohort study

Background & Aims: Conflicting evidence exists on hepatocellular carcinoma (HCC) risk in patients with chronic hepatitis B (CHB) receiving tenofovir vs. entecavir. We assessed the impacts of the two drugs on the clinical trajectory of CHB at a population level. Methods: We conducted a retrospect...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Wan-Jung Wu, Wen-Jie Liu, Chih-Lin Lin, Chun-Jen Liu, Yi-Wen Huang, Jui-Ting Hu, Ming-Whei Yu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2025-10-01
Schriftenreihe:	JHEP Reports
Schlagworte:	Ascites Esophageal varices Non-alcoholic fatty liver disease Severe decompensated cirrhosis Variceal bleeding
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2589555925001892
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!